ISRCTN79705768
Completed
未知
eurodevelopmental outcome after neonatal hypoglycaemia: a multi-centre randomised controlled trial comparing intensive treatment versus expectant glucose monitoring in 'high risk' newborns
Academic Medical Centre (AMC) (The Netherlands)0 sites689 target enrollmentAugust 23, 2007
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Developmental-disabilities, blood-glucose, hypoglycaemia
- Sponsor
- Academic Medical Centre (AMC) (The Netherlands)
- Enrollment
- 689
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
2020 results in https://www.ncbi.nlm.nih.gov/pubmed/32023373 (added 06/02/2020)
Investigators
Eligibility Criteria
Inclusion Criteria
- •Current participant inclusion criteria as 04/09/2019:
- •Infants greater than or equal to 35 weeks gestational age and greater than or equal to 2000 g with one of the four major risk factors for neonatal hypoglycaemia:
- •1\. Small\-for\-Gestational\-Age infants (SGA, birth\-weight\-for\-gestational\-age less than P10\)
- •2\. Large\-for\-Gestational\-Age infants (LGA, birth\-weight\-for\-gestational\-age greater than P90\)
- •3\. Near\-term infants 35 0/7 to 36 6/7 weeks gestational age with a birth weight greater than 2000 g
- •4\. Infants of Diabetic Mothers (IDM)
- •Birth\-weight\-for\-gestational\-age is defined according to the growth charts of the Perinatale Registratie Nederland (PRN).
- •Previous participant inclusion criteria:
- •Infants greater than or equal to 35 weeks gestational age and greater than or equal to 2000 g with one of the four major risk factors for neonatal hypoglycaemia:
- •1\. Small\-for\-Gestational\-Age infants (SGA, birth\-weight\-for\-gestational\-age less than P10\)
Exclusion Criteria
- •Current participant exclusion criteria:
- •Infants with serious co\-morbidity will be excluded, because their co\-morbidity can also affect neurodevelopment:
- •1\. Very preterm infants (less than 34 6/7 weeks gestational age)
- •2\. Severe perinatal asphyxia \- presence of at least three of the next criteria:
- •2\.1\. Signs of intrauterine asphyxia, like late decelerations on Cardiotocogram (CTG) or meconium stained amniotic fluid
- •2\.2\. Arterial umbilical cord pH less than 7\.10
- •2\.3\. Delayed initiation of spontaneous respirations greater than 5 minutes after birth
- •2\.4\. Five minute Apgar score less than 5
- •2\.5\. Multi\-organ failure
- •3\. Severe perinatal infection: requiring support of vital functions (infants without clinical signs of infection who are treated with antibiotics because of suspected perinatal infection can be included)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
eurodevelopmental outcome after neonatal hypoglycemia: a multi-center randomized controlled trial comparing intensive treatment versus expectant glucose monitoring in 'high risk' newborns.NL-OMON23239Academical Medical Center, Amsterdam, The Netherlands800
Not yet recruiting
Not Applicable
EURODEVELOPMENTAL OUTCOME AFTER NEONATAL HYPOGLYCEMIA: A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL COMPARING INTENSIVE TREATMENT VERSUS EXPECTANT GLUCOSE MONITORING IN 'HIGH RISK' NEWBORNS.neonatal hypoglycemialow blood sugar concentration1001842410028920NL-OMON30992Academisch Medisch Centrum800
Not yet recruiting
Not Applicable
eurodevelopmental outcomes by surgery in children operated for congenital heart disease in the neonatal periodKCT0009388Asan Medical Center40
Completed
Not Applicable
eurodevelopmental Outcome after Fetal Neonatal Alloimmune Thrombocytopeniaantibodies against platelets during pregnancy.Fetal neonatal alloimmune thrombocytopenia (FNAIT)100355341001684910012562NL-OMON49430eids Universitair Medisch Centrum63
Completed
Not Applicable
Outcome of Very Preterm Infants With Glucose Level DisturbancesCerebral Palsy InfantileNCT03530189University Hospital Rijeka150